Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Mycophenolate sodium (250mg) Tablet
Therapeutic Category
Immunology, Nephrology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Mycofoli 250 Tablet contains Mycophenolate Sodium 250 mg, a potent immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This tablet works by inhibiting inosine monophosphate dehydrogenase (IMPDH), thereby suppressing T- and B-lymphocyte proliferation and reducing immune-mediated damage to transplanted organs. It is ideal for patients undergoing renal, cardiac, or hepatic transplant regimens requiring careful immunosuppression under medical supervision.
Clinically, Mycofoli 250 Tablet is used in combination with calcineurin inhibitors and corticosteroids to maintain graft survival and minimize rejection episodes.
The tablet ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, transplant centers, specialty pharmacies, and healthcare providers managing post-transplant immunosuppressive therapy.
Common side effects may include gastrointestinal discomfort, nausea, diarrhea, vomiting, headache, and mild infections. Rare but serious effects include severe infections, leukopenia, anemia, thrombocytopenia, or allergic reactions.
Mycofoli 250 Tablet is indicated for the prevention of organ transplant rejection in renal, cardiac, or hepatic transplant recipients. It is also used for the management of certain autoimmune disorders under specialist supervision.
Use Mycofoli 250 Tablet strictly under medical supervision. Regular monitoring of blood counts, liver and kidney function, and infection status is essential. Inform your doctor about any history of infections, bone marrow suppression, or concurrent medications. Avoid live vaccines and contact your physician immediately if persistent fever, unusual bleeding, or severe infections occur.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use beyond the expiry date.
Composition : Carbonyl Iron 100mg + Folic Acid 1.5mg + Zinc Sulphate 61.8mg + Vitamin C 75mg + Cynocabalmin 15mcg Capsule
Composition : Elemental Iron 10mg + Folic Acid 200mcg + Vitamin B12 100mcg
Composition : Iron Sucrose 20mg Injection
Composition : Elemental Iron 100mg/5ml
Composition : Ferric Carboxymaltose (500mg)
Composition : Ferrous Ascorbate (100mg) + Folic Acid (1.5mg) + Zinc (22.5mg)
Composition : Iron & calcium tonic
Composition : Ferrous Bisglycinate 100 mg + Folic Acid 200 mcg (RDA 20%) + Vitamin B12 (Cyanocobalamin) 1 mcg (RDA 100%) + Zinc Sulphate 22.5 mg (RDA 68%) + Sorbitol base q.s. Syrup
Composition : Ferrous Fumarate 19mg + Zinc Sulphate 12mg + Folic Acid 140mcg
Composition : Ferrous Ascorbate 100mg + Folic Acid 1.5mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Mycophenolate Sodium 250mg Tablet has strong demand in the transplant medicine, nephrology, immunology, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty and critical care portfolios.
Medical distributors and agencies can benefit from demand for immunosuppressive therapy under specialist medical supervision. Mycophenolate Sodium 250mg is an immunosuppressive medication that helps suppress immune system activity Commonly prescribed for organ transplant recipients, particularly kidney transplant patients, to help prevent organ rejection Frequently used as part of combination immunosuppressive regimens alongside other transplant medications The lower-strength formulation provides greater dosage flexibility and individualized dose adjustments as determined by healthcare professionals Supports long-term transplant management and graft survival when used according to prescribed treatment protocols Widely prescribed by nephrologists, transplant surgeons, and immunology specialists This strengthens a comprehensive transplant medicine and specialty care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mycophenolate Sodium 250mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from specialty prescription demand, institutional procurement opportunities, long-term therapy requirements, reliable supply chain support, and attractive margins in the transplant and specialty healthcare segment.
Interested distributors, stockists, wholesalers, and pharma professionals can partner with Cafoli LifeCare Pvt Ltd to explore profitable PCD pharma franchise opportunities for Mycophenolate Sodium 250mg Tablet and a wide range of pharmaceutical products. The company offers **monopoly-based franchise rights, attractive profit margins, promotional and marketing support, quality-assured formulations, timely product availability, and dependable